Cancer Letters

Cancer Letters

Volume 370, Issue 2, 28 January 2016, Pages 165-176
Cancer Letters

Original Articles
TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients

https://doi.org/10.1016/j.canlet.2015.10.012Get rights and content

Abstract

Metastasis involves a series of changes in cancer cells that promote their escape from the primary tumor and colonization to a new organ. This process is related to the transition from an epithelial to a mesenchymal phenotype (EMT). Recently, some authors have shown that migratory cells with an EMT phenotype share properties of cancer stem cells (CSCs), which allow them to form a new tumor mass. The type II transmembrane serine protease TMPRSS4 is highly expressed in some solid tumors, promotes metastasis and confers EMT features to cancer cells. We hypothesized that TMPRSS4 could also provide CSC properties. Overexpression of TMPRSS4 reduces E-cadherin and induces N-cadherin and vimentin in A549 lung cancer cells, supporting an EMT phenotype. These changes are accompanied by enhanced migration, invasion and tumorigenicity in vivo. TMPRSS4 expression was highly increased in a panel of lung cancer cells cultured as tumorspheres (a typical assay to enrich for CSCs). H358 and H441 cells with knocked-down TMPRSS4 levels were significantly less able to form primary and secondary tumorspheres than control cells. Moreover, they showed a lower proportion of ALDH+ cells (examined by FACS analysis) and lower expression of some CSC markers than controls. A549 cells overexpressing TMPRSS4 conferred the opposite phenotype and were also more sensitive to the CSC-targeted drug salinomycin than control cells, but were more resistant to regular chemotherapeutic drugs (cisplatin, gemcitabine and 5-fluorouracil). Analysis of 70 NSCLC samples from patients revealed a very significant correlation between TMPRSS4 expression and CSC markers ALDH (p = 0.0018) and OCT4 (p = 0.0004), suggesting that TMPRSS4 is associated with a CSC phenotype in patients' tumors. These results show that TMPRSS4, in addition to inducing EMT, can also promote CSC features in lung cancer; therefore, CSC-targeting drugs could be an appropriate treatment for TMPRSS4+ tumors.

Introduction

Mortality rates in non-small cell lung cancer (NSCLC) patients remain overly high despite the implementation of novel targeted therapies and chemotherapeutic regimes. The main reason for this problem is that tumors are generally diagnosed in the later stages of the disease and that effectiveness of current treatments is either therapeutically insufficient or only beneficial to a small population of patients (in the case of targeted therapies). Therefore, it is clear that identification of new potential therapeutic targets is a priority for the management of NSCLC.

Metastasis involves a series of phenotypic and behavioral changes in cancer cells that allow them to escape from the primary tumor, migrate through lymphatic and/or blood vessels, survive in circulation and colonize a new organ [1]. In order to be fully metastatic, cancerous cells need to modify their transcriptome to adapt to the new microenvironmental conditions that they will encounter in this multi-step process [1]. Proteases play a major role in tumor progression as they induce the degradation of the connective tissue surrounding the cancerous mass and activate growth factors, cytokines and angiogenic factors that need to be cleaved to be fully active [2]. Type II transmembrane serine proteases (TTSPs) belong to a family of enzymes that includes 18 members, some of which have been demonstrated to promote tumorigenesis, such as hepsin, matriptase, HAT/DESC, TMPRSS2 and TMPRSS4 [3].

TMPRSS4 comprises of a short N-terminal cytoplasmic domain, a transmembrane domain and a large extracellular domain that contains its catalytic activity [4]. This protease is highly upregulated in a variety of solid tumors, including pancreas, colon, lung, ovary, breast, cervical carcinoma and thyroid cancers [4], [5], [6]. We have previously demonstrated that TMPRSS4 is overexpressed in lung tumors compared to normal lung, particularly in squamous cell carcinomas compared to adenocarcinomas [7]. Importantly, high TMPRSS4 levels in patients with squamous cell carcinomas are associated with poor prognosis [7]. We have also shown that the depletion of TMPRSS4 levels using shRNA strategies in NSCLC cells causes significant metastatic impairment in animal models [7].

Mechanistic studies have reported that TMPRSS4 induces epithelial to mesenchymal transition (EMT) and promotes metastasis in colon cancer cells [8], [9]. Through EMT, cells confined within the primary tumor are able to detach from neighboring cells by loss of proteins involved in cell–cell contact, such as E-cadherin, and acquire a migratory behavior [10]. Acquisition of the EMT phenotype by TMPRSS4 is mediated by upregulation of integrin-α5β1 and activation of downstream signaling cascades involving FAK, Src, Rac1, ERK1/2 and AKT phosphorylation [11]. Targeted inhibition of PI3K or Src decreases cell invasiveness and actin rearrangement mediated by TMPRSS4 [9]. Through a microarray analysis, we discovered that miR-205 (MIR205HG) was overexpressed upon TMPRSS4 downregulation [12]. Increased miR-205 levels promote an epithelial phenotype with high E-cadherin and low fibronectin levels, thus inhibiting tumor cell migration and metastasis. Moreover, we identified integrin α5β1 as a new miR-205 direct target in NSCLC [12].

Since EMT favors the dissemination of cancer cells to distant organs, it is thought that this process is necessary for efficient metastasis. In addition, to give rise to new metastatic tumor masses, the property of self-renewal seems to be another required trait. This is because disseminated cells have to act as founders of new cancerous colonies. For these reasons, some authors have hypothesized that migratory cells with an EMT phenotype can share properties with cancer stem cells (CSCs) [13]. Current evidence suggests that CSCs are responsible for tumor initiation, cell survival after therapy, metastatic spread and tumor recurrence [14]. CSCs are resistant to regular chemotherapeutic drugs and to radiotherapy [14], [15]. This suggests that many cancer therapies, while shrinking the tumor bulk, may fail overall because they do not eliminate completely the CSC population.

Based on this information we hypothesized that TMPRSS4, an inducer of EMT, could also confer CSC properties. Therefore, the aim of this study was to assess whether TMPRSS4 induced CSC properties in lung cancer models and whether TMPRSS4+ tumors from NSCLC patients would be associated with a CSC phenotype, supporting its role as a tumor promoting gene. Indeed, we have found that the expression of TMPRSS4 is associated with CSC features including tumorigenicity, formation of primary and secondary tumorspheres (a sign of self-renewal), regulation of the CSC marker ALDH, resistance to regular chemotherapy, and increased sensitivity to the CSC-targeted drug, salinomycin. Moreover, TMPRSS4 expression is very significantly correlated with that of ALDH and OCT4 in patients tumor samples. All these results suggest that TMPRSS4 may induce a cancer stem-like cell phenotype that promotes tumorigenesis.

Section snippets

Cell culture

The human lung cancer cell lines H358, H441, H460 and A549 were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). A primary cell line obtained from a pleural effusion (designated as Gon8) that we have previously characterized [16] was also used. The Lacun3 cell line, derived from a murine lung adenocarcinoma after injection of DMNA and silica, has been previously described and characterized by our group [17]. All cell lines were grown and cultured in RPMI

Characterization of TMPRSS4-overexpressing A549 cells

Firstly, we wanted to examine the effect of TMPRSS4 overexpression in cells with low endogenous expression of this protein, as is the case for the A549 cell line [7]. Retroviral particles carrying either the empty vector (as controls; designated as pBABE) or the vector carrying TMPRSS4 (referred to as pB-TMP4) were used. TMPRSS4 expression levels in these cells were measured by RT-PCR and Western blot. In addition, we performed immunohistochemistry as a further validation of protein expression.

Discussion

TMPRSS4, a serine protease that is highly up-regulated in several cancer types, has been shown to promote invasion, tumor growth and metastasis [4]. Although the precise mechanism and signaling cascades are not yet well understood, induction of EMT through up-regulation of integrin-α5 seems to be a critical mechanism for its tumorigenic role. Activation of several extracellular factors by TMPRSS4-mediated proteolysis contributes to metastasis. For example the pro-urokinase-type plasminogen

Conflict of interest

We state that no conflict of interests exist in our study.

Acknowledgements

This work has been funded by RTICC (RD12/0036/0040), FIS (PI13/00093) and MINECO (BIO2013-50458-EXP). Arrate L. de Aberasturi was supported by an “Asociacion de Amigos de la Universidad de Navarra” fellowship; Maria Villalba was supported by an FPU fellowship (FPU-14/03247); Stephanie R. Evans was supported by an ERASMUS fellowship.

References (51)

  • R. Januchowski et al.

    The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance

    Biomed. Pharmacother

    (2013)
  • Y. Lin et al.

    Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells

    Mol. Cell

    (2012)
  • J.A. Ajani et al.

    ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients

    Mol. Oncol

    (2014)
  • R. Riccioni et al.

    The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor

    Blood Cells Mol. Dis

    (2010)
  • Y. Lu et al.

    Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling

    Chem. Biol. Interact

    (2015)
  • D.X. Nguyen et al.

    Metastasis: from dissemination to organ-specific colonization

    Nat. Rev. Cancer

    (2009)
  • C. Lopez-Otin et al.

    The regulatory crosstalk between kinases and proteases in cancer

    Nat. Rev. Cancer

    (2010)
  • A.L. de Aberasturi et al.

    TMPRSS4: an emerging potential therapeutic target in cancer

    Br. J. Cancer

    (2015)
  • A. Ohler et al.

    TMPRSS4 is a type II transmembrane serine protease involved in cancer and viral infections

    Biol. Chem

    (2012)
  • L. Larzabal et al.

    Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology

    Br. J. Cancer

    (2011)
  • H. Jung et al.

    TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition

    Oncogene

    (2008)
  • S. Kim et al.

    TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways

    Carcinogenesis

    (2010)
  • R. Kalluri et al.

    The basics of epithelial-mesenchymal transition

    J. Clin. Invest

    (2009)
  • S. Kim et al.

    Membrane proteins involved in epithelial-mesenchymal transition and tumor invasion: studies on TMPRSS4 and TM4SF5

    Genomics Inform

    (2014)
  • L. Larzabal et al.

    TMPRSS4 regulates levels of integrin alpha5 in NSCLC through miR-205 activity to promote metastasis

    Br. J. Cancer

    (2014)
  • Cited by (39)

    • Moesin-Mediated P-Glycoprotein Activation During Snail-Induced Epithelial-Mesenchymal Transition in Lung Cancer Cells

      2020, Journal of Pharmaceutical Sciences
      Citation Excerpt :

      In the present study, therefore, we first aimed to clarify the role of ERM proteins in P-gp activation associated with Snail-induced EMT in HCC827 lung cancer cells. We also examined the correlations of Snail, ERM, and P-gp mRNA expression levels in HCC827 and 3 other lung cancer cell lines, A549, H441, and H1975, which have previously been used in studies of the relationship of EMT with lung cancer.33,34 Furthermore, we investigated the clinical relevance of our findings by similarly examining clinical samples from patients with lung cancer.

    • Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery

      2019, Cancer Letters
      Citation Excerpt :

      LKR13 cells containing the vectors were selected with puromycin (1 μg/mL). qPCR and Western blot methods were performed as previously described [14]. Sequences of the primers are shown in Supplementary Table 1.

    View all citing articles on Scopus

    IDISNA: Navarra's Health Research Institute.

    View full text